ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

9 links0 made here, not in the record6 judgments2 judges (the rules as one: Rule based)13 record changes seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older version
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05136196BiCaZO: A Study CombiningTwo Immunotherapies(Cabozantinib andNivolumab) to TreatPatients With AdvancedMelanoma or Squamous CellHead and Neck Cancer, anNational Cancer Institute (NCIPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 25 · ClinicalTrials.gov record · Version of 2026-09-25Oct 6 · ClinicalTrials.gov record · Version of 2026-10-06Oct 7 · ClinicalTrials.gov record · Version of 2026-10-07Oct 13 · ClinicalTrials.gov record · Version of 2026-10-13Oct 14 · ClinicalTrials.gov record · Version of 2026-10-14Oct 20 · ClinicalTrials.gov record · Version of 2026-10-20Oct 23 · ClinicalTrials.gov record · Version of 2026-10-23Oct 26 · ClinicalTrials.gov record · Version of 2026-10-26Oct 29 · ClinicalTrials.gov record · Version of 2026-10-29Nov 2 · ClinicalTrials.gov record · Version of 2026-11-02Nov 3 · ClinicalTrials.gov record · Version of 2026-11-03Nov 12 · ClinicalTrials.gov record · Version of 2026-11-12Nov 18 · ClinicalTrials.gov record · Version of 2026-11-18Version of 2026-11-18CONDITIONSOropharyngeal NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionSquamous Cell Carcinoma of …The registry's MeSH filing›No judgment recorded. Shown as the registry files it.MelanomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Hypopharyngeal NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Laryngeal NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Mouth NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.CarcinomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSCabozantinibEntry “Cabozantinib S-malate”, read b…›Nov 2 · Claude Opus 5.5 · BackgroundNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · BackgroundTestedNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Cabozantinib

From the registry record3 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Cabozantinib S-malate”the record gives no role
→judged→changed→changed
How the 3 judgments split33%of judgments with a known value say Tested
Tested · 1
Background · 2

All judgments on this study

WhenLinkJudgeDecisionState
Sep 25The record itselfClinicalTrials.gov recordVersion of 2026-09-25Record change
Oct 6The record itselfClinicalTrials.gov recordVersion of 2026-10-06Record change
Oct 7The record itselfClinicalTrials.gov recordVersion of 2026-10-07Record change
Oct 13The record itselfClinicalTrials.gov recordVersion of 2026-10-13Record change
Oct 14The record itselfClinicalTrials.gov recordVersion of 2026-10-14Record change
Oct 20The record itselfClinicalTrials.gov recordVersion of 2026-10-20Record change
Oct 23The record itselfClinicalTrials.gov recordVersion of 2026-10-23Record change
Oct 26The record itselfClinicalTrials.gov recordVersion of 2026-10-26Record change
Oct 29The record itselfClinicalTrials.gov recordVersion of 2026-10-29Record change
Nov 2CabozantinibClaude Opus 5.5BackgroundReplaced
Nov 2NivolumabClaude Opus 5.5TestedCurrent
Nov 2The record itselfClinicalTrials.gov recordVersion of 2026-11-02Record change
Nov 3CabozantinibClaude Opus 5.5TestedCurrent
Nov 3The record itselfClinicalTrials.gov recordVersion of 2026-11-03Record change
Nov 12The record itselfClinicalTrials.gov recordVersion of 2026-11-12Record change
Nov 18The record itselfClinicalTrials.gov recordVersion of 2026-11-18Record change
Nov 18CabozantinibRule based · role ruleBackgroundOverridden
Nov 18NivolumabRule based · role ruleTestedAgrees
As of nowOropharyngeal NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.